1. Home
  2. BEEM vs HIND Comparison

BEEM vs HIND Comparison

Compare BEEM & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

HOLD

Current Price

$1.69

Market Cap

31.4M

Sector

Technology

ML Signal

HOLD

HIND

Vyome Holdings Inc.

N/A

Current Price

$3.29

Market Cap

28.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BEEM
HIND
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
28.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BEEM
HIND
Price
$1.69
$3.29
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
208.3K
N/A
Earning Date
11-14-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,668,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$45.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
N/A
52 Week High
$4.04
N/A

Technical Indicators

Market Signals
Indicator
BEEM
HIND
Relative Strength Index (RSI) 45.65 34.02
Support Level $1.62 $3.11
Resistance Level $1.72 $3.69
Average True Range (ATR) 0.10 0.25
MACD 0.02 -0.02
Stochastic Oscillator 70.49 22.86

Price Performance

Historical Comparison
BEEM
HIND

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.

Share on Social Networks: